Noradrenergic and opioidergic alterations in neuropathy in different rat strains

Neuroscience Letters

Volumn 438, Issue 2, 2008, Pages 186-189

  Herradon, Gonzalo ^a,b   Ezquerra, Laura ^b   Nguyen, Trang ^b   Wang, Chi ^b   Siso, Ana ^b   Franklin, Barbara ^b   Dilorenzo, Laura ^b   Rossenfeld, Julie ^b   Silos Santiago, Inmaculada ^b   Alguacil, Luis F ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b Millennium Pharmaceuticals Inc   (Spain)

Author keywords

CCI; Dynorphin; Enkephalin; F344; Lewis

Indexed keywords

DELTA OPIATE RECEPTOR; HYDROLASE; OPIATE RECEPTOR; PRODYNORPHIN; PROENKEPHALIN; TYROSINE HYDROLASE;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FISCHER 344 RAT; GENE EXPRESSION; GENE TARGETING; LEWIS RAT; MALE; NERVE COMPRESSION; NERVE SURGERY; NEUROPATHIC PAIN; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCIATIC NERVE; SPINAL CORD; SPINAL GANGLION; STRAIN DIFFERENCE; UPREGULATION;

ANIMALS; CHRONIC DISEASE; DENERVATION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DYNORPHINS; ENKEPHALINS; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; HYPERALGESIA; LIGATION; MALE; NEURONS, AFFERENT; NOREPINEPHRINE; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; PROTEIN PRECURSORS; RATS; RATS, INBRED F344; RATS, INBRED LEW; RECEPTORS, OPIOID, DELTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIES SPECIFICITY; SPINAL CORD; TYROSINE 3-MONOOXYGENASE;

EID: 44149101892     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.03.095     Document Type: Article

References (31)

1. Akbarian S., Rios M., Liu R.J., Gold S.J., Fong H.F., Zeiler S., Coppola V., Tessarollo L., Jones K.R., Nestler E.J., Aghajanian G.K., and Jaenisch R. Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. J. Neurosci. 22 10 (2002) 4153-4162
2. Alguacil L.F., and Morales L. Alpha-2 adrenoceptor ligands and opioid drugs: pharmacological interactions of therapeutic interest. Curr. Neuropharmacol. 2 (2004) 343-352
3. Basbaum A.I., Cruz L., and Weber E. Immunoreactive dynorphin B in sacral primary afferent fibers of the cat. J. Neurosci. 6 1 (1986) 127-133
4. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 1 (1988) 87-107
5. Brumovsky P., Villar M.J., and Hökfelt T. Tyrosine hydroxylase is expressed in a subpopulation of small dorsal root ganglion neurons in the adult mouse. Exp. Neurol. 200 1 (2006) 153-165
6. Cheng H.Y., Pitcher G.M., Laviolette S.R., Whishaw I.Q., Tong K.I., Kockeritz L.K., Wada T., Joza N.A., Crackower M., Goncalves J., Sarosi I., Woodgett J.R., Oliveira-dos-Santos A.J., Ikura M., van der Kooy D., Salter M.W., and Penninger J.M. DREAM is a critical transcriptional repressor for pain modulation. Cell 108 1 (2002) 31-43
7. Ezquerra L., Perez-Garcia C., Garrido E., Diez-Fernandez C., Deuel T.F., Alguacil L.F., and Herradon G. Morphine and yohimbine regulate midkine gene expression in the rat hippocampus. Eur. J. Pharmacol. 557 2/3 (2007) 147-150
8. Ezquerra L., Alguacil L.F., Nguyen T., Deuel T.F., Silos-Santiago I., and Herradon G. Different pattern of pleiotrophin and midkine expression in neuropathic pain: correlation between changes in pleiotrophin gene expression and rat strain differences in neuropathic pain. Growth Factors 26 1 (2008) 44-48
9. Fecho K., and Valtschanoff J.G. Acute inflammatory and neuropathic pain in Lewis and Fischer rats. J. Neuroendocrinol. 18 7 (2006) 504-513
10. Gao X., Zhang Y.Q., and Wu G.C. Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats. Eur. J. Pharmacol. 418 (2001) 73-77
11. Gao X., Zhang Y.Q., Zhang L.M., and Wu G.C. Effects of intraplantar injection of carrageenan on central dopamine release. Brain Res. Bull. 54 (2001) 391-394
12. Gibbins I.L., Furness J.B., and Costa M. Pathway-specific patterns of the co-existence of substance P, calcitonin gene-related peptide, cholecystokinin and dynorphin in neurons of the dorsal root ganglia of the guinea-pig. Cell Tissue Res. 248 2 (1987) 417-437
13. Herradon G., Ezquerra L., Morales L., Franklin B., Silos-Santiago I., and Alguacil L.F. Lewis and Fischer 344 strain differences in alpha 2-adrenoceptors and tyrosine hydroxylase expression. Life Sci. 78 8 (2006) 862-868
14. Herradon G., Ezquerra L., Nguyen T., Wang C., Siso A., Franklin B., Dilorenzo L., Rossenfeld J., AlguacilI L.F., and Silos-Santiago I. Changes in BDNF gene expression correlate with rat strain differences in neuropathic pain. Neurosci. Lett. 420 3 (2007) 273-276
15. Herradon G., Morales L., and Alguacil L.F. Differences of mu-opioid receptors between Lewis and F344 rats. Life Sci. 73 12 (2003) 1537-1542
16. Herradon G., Morales L., Perez-Garcia C., and Alguacil L.F. The contribution of alpha 2-adrenoceptor and opioid receptor mechanisms to antinociception differs in Lewis and Fischer 344 rats. Eur. J. Pharmacol. 465 3 (2003) 251-256
17. Kosten T.A., and Ambrosio E. HPA axis function and drug addictive behaviors: insights from studies with Lewis and Fischer 344 inbred rats. Psychoneuroendocrinology 27 1/2 (2002) 35-69
18. Lai S.L., Gu Y., and Huang L.Y. Dynorphin uses a non-opioid mechanism to potentiate N-methyl-d-aspartate currents in single rat periaqueductal gray neurons. Neurosci. Lett. 247 2/3 (1998) 115-118
19. Laughlin T.M., Vanderah T.W., Lashbrook J., Nichols M.L., Ossipov M., Porreca F., and Wilcox G.L. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain 72 1/2 (1997) 253-260
20. Levant B., and McCarson K.E. D3 dopamine receptors in rat spinal cord: implications for sensory and motor function. Neurosci. Lett. 303 (2001) 9-12
21. Martin-Iverson M.T., Todd K.G., and Altar C.A. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. J. Neurosci. 14 3 Pt 1 (1994) 1262-1270
22. Przewlocki R., and Przewlocka B. Opioids in neuropathic pain. Curr. Pharm. Des. 11 23 (2005) 3013-3025
23. Randic M., Cheng G., and Kojic L. Kappa-opioid receptor agonists modulate excitatory transmission in substantia gelatinosa neurons of the rat spinal cord. J. Neurosci. 15 10 (1995) 6809-6826
24. Schafer M., Carter L., and Stein C. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc. Natl. Acad. Sci. U.S.A. 91 10 (1994) 4219-4223
25. Siuciak J.A., Altar C.A., Wiegand S.J., and Lindsay R.M. Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. Brain Res. 633 1/2 (1994) 326-330
26. Sounvoravong S., Nakashima M.N., Wada M., and Nakashima K. Decrease in serotonin concentration in raphe magnus nucleus and attenuation of morphine analgesia in two mice models of neuropathic pain. Eur. J. Pharmacol. 484 2/3 (2004) 217-223
27. Tang Q., Gandhoke R., Burritt A., Hruby V.J., Porreca F., and Lai J. High-affinity interaction of (des-tyrosyl)dynorphin A(2-17) with NMDA receptors. J. Pharmacol. Exp. Ther. 291 2 (1999) 760-765
28. van Dijken H., Dijk J., Voorn P., and Holstege J.C. Localization of dopamine D2 receptor in rat spinal cord identified with immunocytochemistry and in situ hybridization. Eur. J. Neurosci. 8 (1996) 621-628
29. Wang Z., Gardell L.R., Ossipov M.H., Vanderah T.W., Brennan M.B., Hochgeschwender U., Hruby V.J., Malan Jr. T.P., Lai J., and Porreca F. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J. Neurosci. 21 5 (2001) 1779-1786
30. Xie G.X., Jones K., Peroutka S.J., and Pierce Palmer P. Detection of mRNAs and alternatively spliced transcripts of dopamine receptors in rat peripheral sensory and sympathetic ganglia. Brain Res. 785 (1998) 129-135
31. Zachariou V., and Goldstein B.D. Dynorphin-(1-8) inhibits the release of substance P-like immunoreactivity in the spinal cord of rats following a noxious mechanical stimulus. Eur. J. Pharmacol. 323 2/3 (1997) 159-165